These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35129856)

  • 1. Comprehensive analysis of PTEN-related ceRNA network revealing the key pathways WDFY3-AS2 - miR-21-5p/miR-221-3p/miR-222-3p - TIMP3 as potential biomarker in tumorigenesis and prognosis of kidney renal clear cell carcinoma.
    Zhou X; Liu G; Xu M; Ying X; Li B; Cao F; Cheng S; Xiao B; Cheng M; Liang L; Jia M; Li W; Liu J; Li Z
    Mol Carcinog; 2022 May; 61(5):508-523. PubMed ID: 35129856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA WDFY3-AS2 suppresses proliferation and invasion in oesophageal squamous cell carcinoma by regulating miR-2355-5p/SOCS2 axis.
    Zhang Q; Guan F; Fan T; Li S; Ma S; Zhang Y; Guo W; Liu H
    J Cell Mol Med; 2020 Jul; 24(14):8206-8220. PubMed ID: 32536038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA ADAMTS9-AS2 inhibits cell proliferation and decreases chemoresistance in clear cell renal cell carcinoma via the miR-27a-3p/FOXO1 axis.
    Song EL; Xing L; Wang L; Song WT; Li DB; Wang Y; Gu YW; Liu MM; Ni WJ; Zhang P; Ma X; Zhang X; Yao J; Chen Y; An RH
    Aging (Albany NY); 2019 Aug; 11(15):5705-5725. PubMed ID: 31400752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA WDFY3-AS2 suppresses tumor progression by acting as a competing endogenous RNA of microRNA-18a in ovarian cancer.
    Li W; Ma S; Bai X; Pan W; Ai L; Tan W
    J Cell Physiol; 2020 Feb; 235(2):1141-1154. PubMed ID: 31347170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WDFY3-AS2: A Potential Prognostic Factor and Therapeutic Target Related to Cancer.
    Mou J; Chen J; Wu Y; He Y; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(25):2814-2821. PubMed ID: 36093824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USF1-induced overexpression of long noncoding RNA WDFY3-AS2 promotes lung adenocarcinoma progression via targeting miR-491-5p/ZNF703 axis.
    Ren P; Hong X; Chang L; Xing L; Zhang H
    Mol Carcinog; 2020 Aug; 59(8):875-885. PubMed ID: 32275336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The hsa-miR-3613-5p, a potential oncogene correlated with diagnostic and prognostic merits in kidney renal clear cell carcinoma.
    Ahmadi M; Najari-Hanjani P; Ghaffarnia R; Ghaderian SMH; Mousavi P; Ghafouri-Fard S
    Pathol Res Pract; 2023 Nov; 251():154903. PubMed ID: 37879147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA related prognosis biomarkers from high throughput sequencing data of kidney renal clear cell carcinoma.
    Huang M; Zhang T; Yao ZY; Xing C; Wu Q; Liu YW; Xing XL
    BMC Med Genomics; 2021 Mar; 14(1):72. PubMed ID: 33750388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity-related long noncoding RNA WDFY3-AS2 inhibited cell proliferation and metastasis through Wnt/β-catenin signaling in oral squamous cell carcinoma.
    Lin X; Ding JM; Zheng XZ; Chen JG
    Arch Oral Biol; 2023 Mar; 147():105625. PubMed ID: 36657277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA MALAT1 modified progression of clear cell kidney carcinoma (KIRC) by regulation of miR-194-5p/ACVR2B signaling.
    Ye Y; Zhang F; Chen Q; Huang Z; Li M
    Mol Carcinog; 2019 Feb; 58(2):279-292. PubMed ID: 30334578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network.
    Gong K; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
    PLoS One; 2021; 16(6):e0252452. PubMed ID: 34101736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COLGALT1 is a potential biomarker for predicting prognosis and immune responses for kidney renal clear cell carcinoma and its mechanisms of ceRNA networks.
    Liu S; Yu Y; Wang Y; Zhu B; Han B
    Eur J Med Res; 2022 Jul; 27(1):122. PubMed ID: 35842702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma.
    Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y
    Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of Two Novel Prognostic lncRNAs in Kidney Renal Clear Cell Carcinoma.
    Song J; Peng J; Zhu C; Bai G; Liu Y; Zhu J; Liu J
    Cell Physiol Biochem; 2018; 48(6):2549-2562. PubMed ID: 30121668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma.
    Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T
    BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of HOXA-AS2 inhibits inflammation and apoptosis in podocytes via sponging miRNA-302b-3p to upregulate TIMP3.
    Li X; Yu HM
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4963-4970. PubMed ID: 32432759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long Noncoding RNA WDFY3-AS2 Represses the Progression of Esophageal Cancer through miR-18a/PTEN Axis.
    Kong Q; Li G; Yin G; Li K; Zhang D; Xu W
    J Oncol; 2021; 2021():9951010. PubMed ID: 34194502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.
    Tan J; Wang W; Song B; Song Y; Meng Z
    Biomed Res Int; 2020; 2020():2837906. PubMed ID: 32802839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
    Zhang X; Niu W; Mu M; Hu S; Niu C
    J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.